Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia.

Yoshihiko OokaTetsuhiro ChibaSadahisa OgasawaraTenyu MotoyamaEiichiro SuzukiAkinobu TawadaFumihiko KanaiOsamu Yokosuka

Published in: BioMed research international (2014)

PSE with selective TACE made it possible for patients with HCC and severe thrombocytopenia to receive systemic chemotherapy. Although PSE with TACE was safe and tolerable for most patients, the extent of PSE with TACE in a wide area of the liver may increase the risk for fatal liver failure.

Keyphrases

liver failure
end stage renal disease
ejection fraction
newly diagnosed
hepatitis b virus
chronic kidney disease
prognostic factors
radiofrequency ablation
early onset
radiation therapy
chemotherapy induced